Kenvue Inc
KVUE16.965USD
+0.195+1.16%
Horário de mercado （ET）Cotações atrasadas em 15 min
32.50BValor de mercado
22.68P/L TTM
Mais detalhes de Kenvue Inc Empresa
Kenvue Inc. is a consumer health company. The Company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. Its Self Care product categories include Pain Care; Cough, Cold, and Allergy; and Other Self Care (Digestive Health; Smoking Cessation; Eye Care; and Other). The Skin Health and Beauty segment's product categories include face and body care and hair, sun, and others. The Essential Health segment's product categories include oral care, baby care and other essential health (women’s health, wound care, and other). Its differentiated portfolio of brands includes Tylenol, Neutrogena, Listerine, Johnson’s, Band-Aid, Aveeno, Zyrtec, and Nicorette. The Company has a global footprint through which it sells and distributes its product portfolio in more than 165 countries across its four regions. The four region consists of North America, Asia Pacific (APAC), Europe, Middle East, and Africa (EMEA), and Latin America (LATAM).
Informações de Kenvue Inc
Código da empresaKVUE
Nome da EmpresaKenvue Inc
Data de listagemMay 04, 2023
CEOMr. Kirk L. Perry
Número de funcionários22000
Tipo de títulosOrdinary Share
Fim do ano fiscalMay 04
Endereço1 Kenvue Way
CidadeSUMMIT
Bolsa de valoresNYSE Consolidated
PaísUnited States of America
Código postal07901
Telefone19088741200
Sitehttps://www.kenvue.com
Código da empresaKVUE
Data de listagemMay 04, 2023
CEOMr. Kirk L. Perry
Executivos da empresa Kenvue Inc
Nome
Nome/Posição
Posição
Ações detidas
Variação
Ms. Meredith (Meri) Stevens
Ms. Meredith (Meri) Stevens
Chief Operations Officer
Chief Operations Officer
64.44K
+5.82%
Mr. Carlton Lawson
Mr. Carlton Lawson
Group President, Europe, Middle East and Africa and Latin America
Group President, Europe, Middle East and Africa and Latin America
56.32K
-14.66%
Dr. Caroline Tillett
Dr. Caroline Tillett
Chief Scientific Officer
Chief Scientific Officer
44.13K
+6.62%
Mr. Jan Meurer
Mr. Jan Meurer
Group President, North America
Group President, North America
33.18K
+15.35%
Ms. Luani Alvarado
Ms. Luani Alvarado
Chief People Officer
Chief People Officer
31.36K
+9.72%
Ms. Charmaine England
Ms. Charmaine England
Chief Growth Officer
Chief Growth Officer
29.06K
+5.68%
Mr. Michael E. Sneed
Mr. Michael E. Sneed
Independent Director
Independent Director
28.44K
+52.59%
Mr. Larry J. Merlo
Mr. Larry J. Merlo
Independent Chairman of the Board
Independent Chairman of the Board
27.46K
+124.86%
Mr. Matthew Orlando
Mr. Matthew Orlando
General Counsel
General Counsel
25.25K
+15.69%
Ms. Melanie L. Healey
Ms. Melanie L. Healey
Independent Director
Independent Director
17.80K
+122.51%
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Ms. Meredith (Meri) Stevens
Ms. Meredith (Meri) Stevens
Chief Operations Officer
Chief Operations Officer
64.44K
+5.82%
Mr. Carlton Lawson
Mr. Carlton Lawson
Group President, Europe, Middle East and Africa and Latin America
Group President, Europe, Middle East and Africa and Latin America
56.32K
-14.66%
Dr. Caroline Tillett
Dr. Caroline Tillett
Chief Scientific Officer
Chief Scientific Officer
44.13K
+6.62%
Mr. Jan Meurer
Mr. Jan Meurer
Group President, North America
Group President, North America
33.18K
+15.35%
Ms. Luani Alvarado
Ms. Luani Alvarado
Chief People Officer
Chief People Officer
31.36K
+9.72%
Ms. Charmaine England
Ms. Charmaine England
Chief Growth Officer
Chief Growth Officer
29.06K
+5.68%
Detalhamento da receita
Moeda: USDAtualizado em: seg, 6 de out
Moeda: USDAtualizado em: seg, 6 de out
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2021
FY2020
FY2019
Por EmpresaUSD
Nome
Receita
Proporção
Face and Body Care
691.02M
18.00%
Other Self Care
614.24M
16.00%
Cough, Cold and Allergy
462.64M
12.05%
Other Essential Health
459.70M
11.97%
Oral Care
459.70M
11.97%
Outro
1.15B
30.00%
Sem dados
Por Empresa
Por Região
Por EmpresaUSD
Nome
Receita
Proporção
Face and Body Care
691.02M
18.00%
Other Self Care
614.24M
16.00%
Cough, Cold and Allergy
462.64M
12.05%
Other Essential Health
459.70M
11.97%
Oral Care
459.70M
11.97%
Outro
1.15B
30.00%
Distribuição de ações
Atualizado em: dom, 17 de ago
Atualizado em: dom, 17 de ago
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
The Vanguard Group, Inc.
12.13%
T. Rowe Price Associates, Inc.
8.57%
State Street Investment Management (US)
6.00%
BlackRock Institutional Trust Company, N.A.
5.00%
MFS Investment Management
4.36%
Outro
63.92%
Investidores
Investidores
Proporção
The Vanguard Group, Inc.
12.13%
T. Rowe Price Associates, Inc.
8.57%
State Street Investment Management (US)
6.00%
BlackRock Institutional Trust Company, N.A.
5.00%
MFS Investment Management
4.36%
Outro
63.92%
Tipos de investidores
Investidores
Proporção
Investment Advisor
58.19%
Investment Advisor/Hedge Fund
29.14%
Hedge Fund
5.56%
Research Firm
3.52%
Pension Fund
1.66%
Sovereign Wealth Fund
1.44%
Bank and Trust
1.23%
Family Office
0.23%
Family Office
0.19%
Participação acionária institucional
Atualizado em: qua, 1 de out
Atualizado em: qua, 1 de out
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q3
2127
1.94B
100.91%
-295.23M
2025Q2
2098
1.93B
100.46%
-321.30M
2025Q1
2078
1.95B
101.47%
-298.35M
2024Q4
1944
1.96B
102.60%
-253.31M
2024Q3
1828
1.91B
99.61%
-331.64M
2024Q2
1723
1.90B
99.19%
-79.08M
2024Q1
1598
1.90B
99.47%
-51.94M
2023Q4
1442
1.89B
98.66%
-22.82M
2023Q3
1206
1.90B
99.22%
-343.08M
2023Q2
232
1.95B
101.85%
+1.90B
Ver Mais
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
The Vanguard Group, Inc.
232.38M
12.11%
+4.08M
+1.78%
Jun 30, 2025
T. Rowe Price Associates, Inc.
164.28M
8.56%
-44.09M
-21.16%
Jun 30, 2025
State Street Investment Management (US)
115.02M
5.99%
-5.25M
-4.36%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
95.80M
4.99%
+1.47M
+1.56%
Jun 30, 2025
MFS Investment Management
87.63M
4.57%
-5.46M
-5.86%
Jun 30, 2025
Fidelity Management & Research Company LLC
82.90M
4.32%
-9.47M
-10.25%
Jun 30, 2025
Geode Capital Management, L.L.C.
49.00M
2.55%
+604.95K
+1.25%
Jun 30, 2025
Wellington Management Company, LLP
46.37M
2.42%
-15.10M
-24.56%
Jun 30, 2025
Independent Franchise Partners LLP
31.27M
1.63%
+21.89M
+233.36%
Jun 30, 2025
American Century Investment Management, Inc.
30.27M
1.58%
+8.44M
+38.65%
Jun 30, 2025
Ver Mais
ETFs Relacionados
Atualizado em: qui, 6 de nov
Atualizado em: qui, 6 de nov
Nome
Proporção
Renaissance IPO ETF
9.15%
VanEck Morningstar Wide Moat Value ETF
3.7%
American Century Focused Large Cap Value ETF
3.43%
TBG Dividend Focus ETF
2.84%
Brookstone Value Stock ETF
2.47%
Invesco S&P 500 Equal Weight Consumer Staples ETF
2.42%
Cullen Enhanced Equity Income ETF
2.3%
Consumer Staples Select Sector SPDR Fund
2.12%
ProShares Ultra Consumer Staples
2.09%
VanEck Morningstar Wide Moat ETF
2.01%
Ver Mais
Renaissance IPO ETF
Proporção9.15%
VanEck Morningstar Wide Moat Value ETF
Proporção3.7%
American Century Focused Large Cap Value ETF
Proporção3.43%
TBG Dividend Focus ETF
Proporção2.84%
Brookstone Value Stock ETF
Proporção2.47%
Invesco S&P 500 Equal Weight Consumer Staples ETF
Proporção2.42%
Cullen Enhanced Equity Income ETF
Proporção2.3%
Consumer Staples Select Sector SPDR Fund
Proporção2.12%
ProShares Ultra Consumer Staples
Proporção2.09%
VanEck Morningstar Wide Moat ETF
Proporção2.01%
Dividendo
Um total de
2.32B
USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Jan 16, 2025
KVUE.NB Interim Cash Dividend of gross USD 0.205 paid on Feb 26, 2025 going ex on Feb 12, 2025
Feb 12, 2025
Feb 26, 2025
Feb 12, 2025
Oct 17, 2024
KVUE.NB Final Cash Dividend of gross USD 0.205 paid on Nov 27, 2024 going ex on Nov 13, 2024
Nov 13, 2024
Nov 27, 2024
Nov 13, 2024
Jul 25, 2024
KVUE.NB Interim Cash Dividend of gross USD 0.205 paid on Aug 28, 2024 going ex on Aug 14, 2024
Aug 14, 2024
Aug 28, 2024
Aug 14, 2024
Apr 25, 2024
KVUE.NB Interim Cash Dividend of gross USD 0.2 paid on May 22, 2024 going ex on May 07, 2024
May 08, 2024
May 22, 2024
May 07, 2024
Jan 25, 2024
KVUE.NB Interim Cash Dividend of gross USD 0.2 paid on Feb 28, 2024 going ex on Feb 13, 2024
Feb 14, 2024
Feb 28, 2024
Feb 13, 2024
Oct 26, 2023
KVUE.NB Final Cash Dividend of gross USD 0.2 paid on Nov 22, 2023 going ex on Nov 07, 2023
Nov 08, 2023
Nov 22, 2023
Nov 07, 2023
Jul 20, 2023
KVUE.NB Interim Cash Dividend of gross USD 0.2 paid on Sep 07, 2023 going ex on Aug 25, 2023
Aug 28, 2023
Sep 07, 2023
Aug 25, 2023
Desdobramento de ações
Data
Tipo
Proporção
Sem dados
Data
Tipo
Proporção
Sem dados
